A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants

Clinical trial NCT05036512 · COMPLETED

Trial details

NCT number: NCT05036512
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2020-12-09
Primary completion: 2022-11-02
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.